지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수2
CHAPTER I. Literature review and research objectives 11. Black soybean 22. Isoflavone 42.1. Chemical characteristics of isoflavone 42.2. Physiological activity of isoflavone 62.3. Biosynthesis of isoflavone 112.4. Conversion of isoflavone 133. Soy peptide 153.1. Chemical characteristics of soy-protein 153.2. Physiological activity of soy-peptide 163.3. Conversion of soy-peptide 194. Soyasaponin 224.1. Chemical characteristics of soyasaponin 224.2. Physiological activity of soyasaponin 254.3. Biosynthesis of soyasaponin 295. Germination 326. High hydrostatic pressure (HHP) 367. Research objective 43References 44CHAPTER II. Conversion and physiological characteristics of phenolic compound in black soybean after germination and high hydrostatic pressure treatment 72Abstract 731. Introduction 752. Materials and methods 782.1. Materials 782.2. Sample Preparation 782.2.1. Germination 782.2.2. High hydrostatic pressure(HHP) treatment 792.2.3. Extraction of phenolic compound 792.3. Analysis of phenolic compound 822.3.1. Total polyphenol contents 822.3.2. Total flavonoid contents 822.3.3. Phenolic acid composition 832.3.4. Isoflavone composition 842.3.5. Anthocyanin composition 842.4. Physiological activities of phenolic compound 852.4.1. Anti-oxidant activity 852.4.2. Cell culture and cytotoxicity 862.4.3. Estrogenic activity in MCF-7 cancer cells 872.4.4. Anti-estrogenic activity in MCF-7 cancer cells 872.5. Statistical analysis 883. Results and discussion 893.1. Conversion characteristics of phenolic compound in black soybean 893.1.1. Total polyphenol and flavonoid contents 893.1.2. Phenolic acid composition 953.1.3. Isoflavone composition 1043.1.4. Anthocyanin composition 1143.2. Physiological activities of phenolic compound extract 1203.2.1. Anti-oxidant activity 1203.2.2. Estrogenic/anti-estrogenic activity in MCF-7 cancer cells 1233.3. Correlation analysis for selection of marker compound 1283.3.1. Correlation between phenolic compound and estrogenic activity 1283.3.2. Estrogenic activity of single compound for selection of marker compound 132References 135CHAPTER III. Conversion, physiological characteristics and identification of bioactive peptide in black soybean after germination and high hydrostatic pressure treatment 142Abstract 1431. Introduction 1452. Materials and methods 1472.1. Materials 1472.2. Sample Preparation 1472.2.1. Germination 1472.2.2. High hydrostatic pressure(HHP) treatment 1472.2.3. Extraction of soluble protein 1482.3. Analysis of protein and peptide characteristics 1492.3.1. Soluble protein contents 1492.3.2. Electrophoresis analysis (SDS PAGE) 1492.3.3. Low molecular weight (<3 and <10 kDa) peptide contents 1502.3.4. Free amino acid composition 1502.4. Physiological activities of protein extract 1512.4.1. Anti-oxidant activity 1512.4.2. ACE inhibitory activity 1522.4.3. Anti-inflammatory activities in raw 264.7 cell 1532.5. Isolation and identification of active compound 1542.5.1. Isolation in ultrafiltration (MWCO) 1542.5.2. Gel permeation column chromatography (MPLC, Sepadex G15) 1552.5.3. Purification of active compound by 1st semi-preparative HPLC 1552.5.4. Purification of active compound by 2nd semi-preparative HPLC 1562.5.5. Identification of active compound by UV, LC/MS and NMR 1563. Result and discussion 1633.1. Conversion characteristics of protein and peptide in black soybean 1633.1.1. Extraction yield and soluble protein content 1633.1.2. Electrophoresis analysis (SDS-PAGE) 1663.1.3. Low molecular weight peptide content 1693.1.4. Free amino acid composition 1733.2. Physiological activities of protein extract 1763.2.1. Anti-oxidant activity 1763.2.2. ACE inhibitory activity 1803.2.3. Anti-inflammatory activity in raw 264.7 cells 1823.3. Isolation and identification of active compound 1893.3.1. Isolation in ultrafiltration (MWCO) 1893.3.2. Gel permeation column chromatography (MPLC, Sepadex G15) 1913.3.3. Purification of active compound by 1st semi-preparative HPLC 1953.3.4. Purification of active compound by 2nd semi-preparative HPLC 1993.3.5. Identification of active compound by UV, LC/MS and NMR 2054. References 214CHAPTER IV. Conversion, physiological characteristics and identification of bioactive soyasaponin in black soybean after germination and high hydrostatic pressure treatment 222Abstract 2231. Introduction 2252. Materials and methods 2272.1. Materials 2272.2. Sample Preparation 2272.2.1. Germination 2272.2.2. High hydrostatic pressure(HHP) treatment 2282.2.3. Extraction of crude soyasaponin 2282.3. Analysis of Soya-saponin contents 2292.3.1. Crude soyasaponin contents 2292.3.2. Soyasaponin composition 2292.4. Physiological activities of crude soyasaponin extract 2302.4.1. Anti-cancer activity against MCF-7, HCT-116, AGS and PC-3 cell 2302.4.2. Anti-inflammatory activities in RAW 264.7 cell 2322.4.3. Anti-obesity activities in 3T3-L1 adipocyte cell 2342.5. Isolation and identification of active compound 2352.5.1. Preparation of curde-sosaponin 2352.5.2. 1st C18 column chromatography (MPLC) 2362.5.3. 2nd C18 column chromatography (MPLC) 2372.5.4. Purification of active compound by 1st semi-preparative HPLC 2372.5.5. Purification of active compound by 2nd semi-preparative HPLC 2382.5.6. Identification of active compound by UV, LC/MS and NMR 2383. Result and discussion 2453.1. Conversion characteristics of soyasaponin in black soybean 2453.1.1. Extraction yield and crude soyasaponin content 2453.1.2. Soyasaponin composition 2483.2. Physiological activities of crude soyasaponin extract 2543.2.1. Anti-cancer activity against MCF-7, HCT-116, AGS and PC-3 cell 2543.2.2. Anti-obesity activities in 3T3-L1 adipocyte cell 2633.2.3. Anti-inflammatory activity in RAW 264.7 cells 2673.3. Isolation and identification of active compound 2743.3.1. 1st C18 column chromatography (MPLC) 2743.3.2. 2nd C18 column chromatography (MPLC) 2493.3.3. Purification of active compound by 1st semi-preparative HPLC 2833.3.4. Purification of active compound by 2nd semi-preparative HPLC 2873.3.5. Identification of active compound by UV, LC/MS and NMR 2943.4. Changes in maker peptide with different HHP and germination condition 3143.5. Selection of marker compound 3184. References 319CHAPTER V. Identification on factors affecting maker compound conversion in black soybean after germination and high hydrostatic pressure treatment 327Abstract 3281. Introduction 3292. Materials and methods 3312.1. Materials 3312.2. Sample preparation 3312.2.1. Germination 3312.2.2. Enzyme inactivation 3322.2.3. High hydrostatic pressure(HHP) treatment 3322.3. Analysis of maker compound contents 3332.3.1. Isoflavone 3332.3.2. Peptide 3342.3.3. Soyasaponin 3352.4. Statistical analysis 3373. Result and discussion 3373.1. Conversion characteristics of isoflavone with enzyme inactivation 3373.2. Conversion characteristics of peptide with enzyme inactivation 3403.3. Conversion characteristics of soyasaponin with enzyme inactivation 3434. References 345CHAPTER VI. Conclusion 347SUMMARY IN KOREAN 353
0